G01N2333/90283 - CPC Classification Index

#1

20260126444

2026-05-07

Biomarkers for Long COVID

#2

20250388697

2025-12-25

ANTI-SOD1 NANOBODIES

#3

20250263772

2025-08-21

TEST METHOD FOR PHYSICAL FRAILTY, TEST REAGENT FOR PHYSICAL FRAILTY, METHOD FOR SCREENING THERAPEUTIC CANDIDATE SUBSTANCE FOR PHYSICAL FRAILTY, TEST MELTHOD FOR MENTAL FRAILTY, TEST REAGENT FOR MENTAL FRAILTY, AND METHOD FOR SCREENING THERAPEUTIC CNADIDATE SUBSTANCE FOR MENTAL FRAILTY

#4

20250195628

2025-06-19

ANALYTICAL METHOD AND THERAPEUTICAL AGENT FOR USE IN COMBINATION WITH L-ASPARAGINASE IN TUMOUR THERAPY

#5

20240418734

2024-12-19

BIOMARKERS USEFUL IN THE TREATMENT OF SUBJECTS HAVING DISEASES OF THE EYE

#6

20240254256

2024-08-01

Human Anti-SOD1 Antibodies

#7

20230392181

2023-12-07

METHODS FOR DETECTING ZEROVALENT NANOPARTICLE-MEDIATED OXIDATIVE STRESS IN CYANOBACTERIA

#8

20230176073

2023-06-08

Assays and methods for targeted treatment of hydrosalpinx

#9

20230035402

2023-02-02

MISFOLDED SOD1 ASSAY

#10

20220267471

2022-08-25

Human Anti-SOD1 Antibodies

#11

20220184033

2022-06-16

METHODS FOR PREDICTING AND REDUCING THE RISK OF PRETERM BIRTH

#12

20220146533

2022-05-12

Biomarkers useful in the treatment of subjects having diseases of the eye

#13

20220025068

2022-01-27

ANTI SUPEROXIDE DISMUTASE 1 (SOD1) ANTIBODIES AND USE THEREOF

#14

20200386761

2020-12-10

SPECIFIC BIOMARKER SET FOR NON-INVASIVE DIAGNOSIS OF LIVER CANCER

#15

20190365666

2019-12-05

METHODS FOR PREVENTION AND TREATMENT OF CARDIOMETABOLIC SYNDROME AND COMPOSITIONS USED THEREIN

#16

20190346457

2019-11-14

ASSAYS AND METHODS FOR DETECTION AND TARGETED TREATMENT OF HYDROSALPINX

#17

20190302120

2019-10-03

Methods for detection, staging, and surveillance of colorectal adenomas and carcinomas

#18

20190284302

2019-09-19

Human anti-SOD1 antibodies

#19

20190271676

2019-09-05

Biological toxicity test method for evaluating the ecological safety of advanced oxidation processes

#20

20180311292

2018-11-01

PRODUCTS AND METHODS

#21

20180079825

2018-03-22

METHODS AND COMPOSITIONS TO TREAT AND DETECT MISFOLDED-SOD1 MEDIATED DISEASES

#22

20170370945

2017-12-28

Biomarkers useful in the treatment of subjects having diseases of the eye

#23

20170192020

2017-07-06

METHODS OF DIAGNOSING ALS

#24

20170168061

2017-06-15

Specific biomarker set for non-invasive diagnosis of liver cancer

#25

20170074865

2017-03-16

Dry chemical test strip with multiple layers of membranes based on concentration gradient

#26

20160287530

2016-10-06

METHODS FOR PREVENTION AND TREATMENT OF CARDIOMETABOLIC SYNDROME AND COMPOSITIONS USED THEREIN

#27

20160231323

2016-08-11

PROTECTION OF TCR SIGNALING CHAINS IN CANCER PATIENTS AND ENHANCEMENT OF CAR-T CELL THERAPY

#28

20160195550

2016-07-07

METABOLISM OF SOD1 IN CSF

#29

20160193303

2016-07-07

Leveraging oxidative stress pathways in lactic acid bacteria to promote gut homeostasis

#30

20160168267

2016-06-16

Human anti-SOD1 antibodies

#31

20150307573

2015-10-29

CYLINDRINS AS ETIOLOGIC AGENTS OF AMYLOID DISEASES

#32

20140370047

2014-12-18

Products and methods

#33

20140364334

2014-12-11

CONGESTIVE HEART FAILURE BIOMARKERS

#34

20140348822

2014-11-27

Methods and compositions to treat and detect misfolded-SOD1 mediated diseases

#35

20140341927

2014-11-20

Antibodies and their use in the treatment, prevention and diagnosis of a disease associated with SOD1 abnormalities

#36

20140335538

2014-11-13

Methods of diagnosing ALS

#37

20120258468

2012-10-11

INDICATOR AGENT FOR NONINFLAMMATORY STRESS RESPONSE AND USE THEREOF

#38

20120077212

2012-03-29

Methods of diagnosing ALS

#39

20110305701

2011-12-15

Methods and compositions to treat and detect misfolded-SOD1 mediated diseases

#40

20110165594

2011-07-07

SYSTEMIC MARKERS FOR ASTHMA AND ANALOGOUS DISEASES

#41

20110135673

2011-06-09

Antibodies that bind ALS specific epitopes and methods of making

#42

20110124018

2011-05-26

Detection of pathogenic abeta using an epitope protection assay

#43

20100279943

2010-11-04

Cytoplasmic malate dehydrogenase (MDH1) targeted treatment for neurodegenerative diseases

#44

20100028931

2010-02-04

Methods for identifying agents that affect the survival of motor neurons

#45

20090239243

2009-09-24

Method of identifying compounds useful to treat neuronal degenerative diseases

#46

20090233866

2009-09-17

Screening Methods And The Use Of Agents Identified Using The Same

#47

20090098151

2009-04-16

ALS-specific peptide composition

#48

20090068194

2009-03-12

Antibodies and their use in the treatment, prevention and diagnosis of a disease associated with SOD1 abnormalities

#49

20090004683

2009-01-01

Indicator Agent for Noninflammatory Stress Response and Use Thereof

#50

20080305511

2008-12-11

Method for screening antioxidant using mutant bacteria and chlorophyllide, and antioxidant screened by the method

#51

20080299599

2008-12-04

FLUORESCENT PROTEINS FOR MONITORING INTRACELLULAR SUPEROXIDE PRODUCTION

#52

20080206792

2008-08-28

Method of identifying compounds useful to treat neuronal degenerative diseases

#53

20080181872

2008-07-31

AAV VECTORS ENCODING SUPEROXIDE DISMUTASE

#54

20080031817

2008-02-07

Inhibition Of Superoxide Dismutase By Tetrathiomolybdate: Identification Of New Anti-Angiogenic And Antitumor Agents

#55

20080004243

2008-01-03

Method for predicting susceptibility to radiation pneumonitis

#56

20070292410

2007-12-20

Methods and compositions to treat and detect misfolded-SOD1 mediated diseases

#57

20070265350

2007-11-15

METHOD OF IDENTIFYING COMPOUNDS USEFUL TO TREAT NEURONAL DEGENERATIVE DISEASES

#58

20070202537

2007-08-30

BIOMARKERS FOR ALS

#59

20070003977

2007-01-04

Epitope protection assay and method for detecting protein conformations

#60

20060246517

2006-11-02

ALS-specific peptide composition

#61

20060211079

2006-09-21

Systemic markers for asthma and analogous diseases